Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Eunhak SeongShambhunath BoseSong-Yi HanEun-Ji SongMyeongjong LeeYoung-Do NamHojun KimPublished in: The EPMA journal (2021)
In this study, the effects of KRG on the glucose metabolism in MS patients were influenced by the relative abundances of gut microbial population and differed according to the individual enterotype. Therefore, the analysis of enterotype categories is considered to be helpful in predicting the effectiveness of KRG on glucose homeostasis of MS patients individually. This will further help to decide on the appropriate treatment strategy for MS, in compliance with the perspective of PPPM.
Keyphrases
- clinical trial
- end stage renal disease
- metabolic syndrome
- double blind
- mass spectrometry
- chronic kidney disease
- ejection fraction
- newly diagnosed
- multiple sclerosis
- placebo controlled
- randomized controlled trial
- study protocol
- systematic review
- peritoneal dialysis
- adipose tissue
- cardiovascular disease
- radiation therapy
- squamous cell carcinoma
- blood pressure
- skeletal muscle
- microbial community
- weight loss
- patient reported
- combination therapy